Innovation
Sepul Bio, an innovative business unit of Théa, announces the completion of enrollment in the Phase 2b LUNA clinical trial evaluating Ultevursen in patients with USH2A-associated retinitis pigmentosa. This milestone marks an important step in the...
7/24/26
Théa
Théa and Unither Pharmaceuticals announce a strategic long-term industrial partnership to develop a new ophthalmic production facility in Gannat, France. Dedicated to the manufacturing of Théa’s sterile ophthalmic products, this facility will supp...
7/23/26
Fondation Théa
Awarded annually during the congress of the Société Française d’Ophtalmologie, the Jean & Jacques Chibret Prize recognizes leading figures in African ophthalmology. In 2026, this prestigious distinction from the Fondation Théa honors Professor Fat...
5/5/26
Théa
The launch of Initiative Pharma represents a significant step forward for France’s pharmaceutical sector. The initiative brings together companies committed to investing and innovating locally, with a clear objective: strengthening health sovereig...
4/13/26
Welcome to our testimonials section. Discover the inspiring stories of our employees, managers and healthcare professionals who share their experience with Laboratoires Théa.
General Direction
Read the interview with Jean-Frédéric Chibret, President of Théa
Joining Théa means opening your eyes to opportunities for professional development. Training, career development, international mobility... our skills development program supports you throughout your career.
Ready to join the Théa adventure? We're looking for profiles and personalities ready to innovate, whatever their field of expertise.
